Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen
Conditions:   Cirrhosis, Liver;   Vaccination Failure;   HBV;   Vaccine Reaction Interventions:   Drug: IMIQUIMOD cream;   Biological: HEPATITIS B SURFACE ANTIGEN Sponsor:   Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2021 Category: Research Source Type: clinical trials